U.S. scientists are trying to develop stem cell lines by using tissue samples derived from patients with Huntington's disease, sickle cell anemia and Fanconi anemia. These cell lines could help researchers track the progression of various diseases and aid them in testing drugs that might treat biochemical abnormalities.

Related Summaries